Search Results
Adam Brufsky, MD, PhD: Choices of Therapy
Adam Brufsky, MD, PhD: Expectations of Therapy in Breast Cancer
Treating Bone Mets with Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD, discusses the issue of resistance to HER2-targeted therapy
Adam Brufsky, MD, PhD: Clinical Trial Data Supporting These Choices
Dr Adam Brufsky Outlines Care Coordination in Oncology
Adam Brufsky, MD, PhD, elaborates on the clinical implications of DESTINY-Breast01 from SABCS 2020
Adam Brufsky, MD, PhD, considers the investigation of poziotinib in HER2+ metastatic breast cancer
Dr. Brufsky on Challenges in Breast Cancer
An Overview of Immunotherapy in Breast Cancer - An Interview with Adam Brufsky
Dr Adam Brufsky Discusses Value Coordinates of Breast Cancer Care
Dr. Brufsky Discusses Resistance to HER2-Targeted Therapies
